Assembly Biosciences has evolved into a strategically financed antiviral platform, underpinned by a robust partnership with Gilead. Learn why ASMB stock is a buy.
14h
‘Walking Ebola’ helps explain why Congo’s outbreak is so hard to stop – and how to treat it
Overcrowded Ebola units are allowing infected people to remain in their communities longer. Read more at straitstimes.com.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results